HG Porfolio|Huaige Capital Participates in New Round of Nearly 100 million RMB Financing of Leads Bi
Nanjing Leads Biolabs Co., Ltd (“Leads Biolabs” or “company”), a Nanjing-based biotech specialized in the development of tumor immunotherapy, announced successful completion of a new round of financing, raising nearly 100 million RMB. This financing was jointly funded by existing investors including Shanghai CCB Capital, Ennovation Venture,
More
